[February 26, 2015]

Flex Pharma Presenting at Three Upcoming Investor Conferences in March 2015

Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions, today announced that it will present a corporate overview at the following upcoming investor conferences in March:

• The 35^th Annual Cowen and Company Healthcare Conference on March 4, 2015 at 9:20 a.m. ET in Boston, MA;
• The 27^th Annual Roth Conference on March 10, 2015 at 11:30 a.m. PT in Dana Point, CA (News - Alert); and
• The Barclays Capital Healthcare Conference on March 12, 2015 at 2:35 p.m. ET in Miami, FL.

A live webcast of Flex Pharma's presentations at these conferences ma be accessed in the Investor section of the Company's website at www.flex-pharma.com. Please log on to the Flex Pharma website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Flex Pharma's website for 2 weeks following each presentation.

About Flex Pharma

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions. In three randomized, blinded, placebo-controlled, cross-over studies, Flex Pharma's proprietary treatment has shown a statistically significant reduction in the intensity of muscle cramps in healthy normal volunteers.

Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel (News - Alert) Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chairman and Chief Executive Officer Christoph Westphal, M.D., Ph.D.

[ Back To TMCnet.com's Homepage ]